(RTTNews) - Cumberland Pharmaceuticals Inc. (CPIX) said that a single-center, randomized, double-blind, placebo-controlled study results demonstrated that Caldolor Injection significantly reduces the quantity of opioids required to manage pain after a traumatic injury with fracture. In Monday pre-market trade, CPIX is currently trading at $4.36 up $1.07 or 32.52 percent. In addition, the time to first narcotic medication was longer in the Caldolor group than with hospital standard of care.